PLATINUM2023

The V Foundation

Victory Over Cancer®

aka The V Foundation for Cancer Research   |   Cary, NC   |  https://www.v.org/
GuideStar Charity Check

The V Foundation

EIN: 13-3705951


Mission

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State University basketball coach, and ESPN commentator. The V Foundation has funded over $310 million in game-changing cancer research grants nationwide through a competitive process strictly supervised by a world-class Scientific Advisory Committee. Because the V Foundation has an endowment to cover administrative expenses, 100% of direct donations are awarded to cancer research and programs. The V team is committed to accelerating Victory Over Cancer®. To learn more, visit v.org.

Ruling year info

1993

Chief Executive Officer

Shane Jacobson

Main address

14600 Weston Parkway

Cary, NC 27513 USA

Show more contact info

EIN

13-3705951

Subject area info

Health

Population served info

People with diseases and illnesses

NTEE code info

Cancer Research (H30)

Cancer (G30)

Fund Raising and/or Fund Distribution (H12)

What we aim to solve

SOURCE: Self-reported by organization

The V Foundation is working to achieve Victory Over Cancer® by funding game-changing research and all-star scientists.

Our programs

SOURCE: Self-reported by organization

What are the organization's current programs, how do they measure success, and who do the programs serve?

Cancer Research

The V Foundation for Cancer Research currently awards five types of grants.

V Scholar Grant: Three-year grant of $200,000 per year. It supports young tenure-track faculty by funding projects that are either laboratory-based fundamental research or translational research.

Translational Grant: Four-year grant of $200,000 per year. These grants support “bench to bedside” research, whose endpoint is often planning or initiation of a clinical trial.

All-Star Grant: Re-investment in previous V Scholar or Translational grant recipients who are invited to apply for a $1,000,000 grant payable over 5 years. Any type of cancer research is permitted.

Designated Grant: Supports basic or translational research at research institutions and may support outstanding research outside our standing list of NCI-Designated cancer centers. To trigger a new stand-alone grant opportunity, $3,000,000 must be raised.

Mission Grant: Supports educational projects (ex: increase clinical trial enrollment).

Population(s) Served
People with diseases and illnesses

Where we work

Our results

SOURCE: Self-reported by organization

How does this organization measure their results? It's a hard question but an important one.

Total number of grants awarded

This metric is no longer tracked.
Totals By Year
Related Program

Cancer Research

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Total dollar amount of grants awarded

This metric is no longer tracked.
Totals By Year
Related Program

Cancer Research

Type of Metric

Output - describing our activities and reach

Direction of Success

Increasing

Our Sustainable Development Goals

SOURCE: Self-reported by organization

Learn more about Sustainable Development Goals.

Goals & Strategy

SOURCE: Self-reported by organization

Learn about the organization's key goals, strategies, capabilities, and progress.

Charting impact

Four powerful questions that require reflection about what really matters - results.

The V Foundation is working to achieve Victory Over Cancer® by funding game-changing research and all-star scientists.

The V Foundation is well-positioned to fund game-changing research and all-star scientists to accelerate Victory Over Cancer® due to the following key elements of who we are:

• 100% of direct donations go to all types of cancer research and programs. An endowment covers
administrative expenses. 

• Donations go to the best and brightest scientists, from all backgrounds who are researching all
types of cancer. How do we find the best and brightest? Through our world-renowned Scientific Advisory
Committee (comprised of the nation's top doctors and scientists) that reviews and recommends the best
proposals for funding submitted from the 72 National Cancer Institute designated cancer centers and
other exceptional institutions across North America.

• Not only do we fund the best – we are the best stewards of your dollars. The V Foundation has received
11 consecutive 4-star ratings (out of 4) from Charity Navigator, a leading charity evaluator, placing us
among the top 2% of charities evaluated. 

• These three facts work to support our mission - We fund game-changing research and all-star scientists to
accelerate Victory Over Cancer® and save lives. 

• Our vision: Victory Over Cancer®

Leadership – The V Foundation's board of directors is comprised of prominent business leaders, award-winning athletes and coaches, distinguished physicians and outstanding journalists and entertainers. Board members serve on a volunteer basis and provide their expertise for the strategic leadership and governance of the Foundation.

Scientific Advisory Committee – The service of the V Foundation's preeminent and dedicated Scientific Advisory Committee ensures that the Foundation is strategic in its grant-making and only funds the best of the best research proposals. The Scientific Advisory Committee has worked with staff to construct a comprehensive grant evaluation program to measure the impact of past grants on scientific progress.

Corporate Partnerships – The V Foundation works with several corporate partners, including our founding partner ESPN, who use their substantial resources to spread the word of the Foundation's mission and to expose it to potential new donors.

Staff – As the V Foundation has grown in stature and significance in recent years, the staff has likewise grown to support its increased operations. Staff and other administrative costs are covered by the Foundation's endowment.

The V Foundation, since its founding, has awarded more than $310 million in grants to support cancer research. Even more impressive is that these investments has directly leveraged an additional $1 billion+ in funding for cancer research.

These grants, however, are not only about quantity, but also quality. Because of the exclusivity and flexibility of the V Foundation's funding mechanisms, the Foundation has been able to fund the most promising and most needed cancer research projects. Further, the V Foundation has remained true to its support of collaborative efforts and has emphasized shared knowledge and partnerships whenever possible.

By funding the best and brigtest scientists, the V Foundation is accelerating the pace of progress. The cancer death rate has fallen by 33% since 1991, but there is more work to do. With its continued focus on research outcomes and responsible stewardship, the V Foundation has remained committed to its goal of providing hope and saving more lives through cancer research

Financials

The V Foundation
Fiscal year: Oct 01 - Sep 30
Financial documents
2019 The V Foundation 2017 2009 Audited Financials
done  Yes, financials were audited by an independent accountant. info

Revenue vs. expenses:  breakdown

SOURCE: IRS Form 990 info
NET GAIN/LOSS:    in 
Note: When component data are not available, the graph displays the total Revenue and/or Expense values.

Liquidity in 2023 info

SOURCE: IRS Form 990

1.89

Average of 1.89 over 10 years

Months of cash in 2023 info

SOURCE: IRS Form 990

7.3

Average of 10.2 over 10 years

Fringe rate in 2023 info

SOURCE: IRS Form 990

24%

Average of 26% over 10 years

Funding sources info

Source: IRS Form 990

Assets & liabilities info

Source: IRS Form 990

Financial data

SOURCE: IRS Form 990

The V Foundation

Revenue & expenses

Fiscal Year: Oct 01 - Sep 30

SOURCE: IRS Form 990 info

Fiscal year ending: cloud_download Download Data

The V Foundation

Balance sheet

Fiscal Year: Oct 01 - Sep 30

SOURCE: IRS Form 990 info

The balance sheet gives a snapshot of the financial health of an organization at a particular point in time. An organization's total assets should generally exceed its total liabilities, or it cannot survive long, but the types of assets and liabilities must also be considered. For instance, an organization's current assets (cash, receivables, securities, etc.) should be sufficient to cover its current liabilities (payables, deferred revenue, current year loan, and note payments). Otherwise, the organization may face solvency problems. On the other hand, an organization whose cash and equivalents greatly exceed its current liabilities might not be putting its money to best use.

Fiscal year ending: cloud_download Download Data

The V Foundation

Financial trends analysis Glossary & formula definitions

Fiscal Year: Oct 01 - Sep 30

SOURCE: IRS Form 990 info

This snapshot of The V Foundation’s financial trends applies Nonprofit Finance Fund® analysis to data hosted by GuideStar. While it highlights the data that matter most, remember that context is key – numbers only tell part of any story.

Created in partnership with

Business model indicators

Profitability info 2019 2020 2021 2022 2023
Unrestricted surplus (deficit) before depreciation -$7,668,028 $13,303,437 $11,687,553 -$6,564,145 $5,935,255
As % of expenses -23.2% 70.9% 44.1% -19.9% 11.8%
Unrestricted surplus (deficit) after depreciation -$7,754,898 $13,213,436 $11,587,143 -$6,673,923 $5,828,742
As % of expenses -23.4% 70.0% 43.6% -20.2% 11.6%
Revenue composition info
Total revenue (unrestricted & restricted) $33,522,505 $19,512,235 $32,236,754 $38,304,202 $47,813,363
Total revenue, % change over prior year -16.4% -41.8% 65.2% 18.8% 24.8%
Program services revenue 0.0% 0.0% 0.0% 0.0% 0.0%
Membership dues 0.0% 0.0% 0.0% 0.0% 0.0%
Investment income 5.4% 5.4% 3.1% 3.9% 4.9%
Government grants 0.0% 0.0% 0.0% 0.0% 0.0%
All other grants and contributions 94.9% 90.7% 90.3% 95.6% 94.6%
Other revenue -0.4% 3.9% 6.6% 0.5% 0.5%
Expense composition info
Total expenses before depreciation $33,042,754 $18,773,498 $26,494,141 $32,960,232 $50,301,280
Total expenses, % change over prior year 7.1% -43.2% 41.1% 24.4% 52.6%
Personnel 9.3% 19.0% 12.3% 11.8% 9.2%
Professional fees 1.3% 2.3% 1.5% 2.2% 1.9%
Occupancy 0.3% 0.7% 0.6% 0.3% 0.3%
Interest 0.0% 0.0% 0.0% 0.0% 0.0%
Pass-through 84.0% 70.6% 81.2% 79.9% 82.9%
All other expenses 5.1% 7.4% 4.4% 5.8% 5.7%
Full cost components (estimated) info 2019 2020 2021 2022 2023
Total expenses (after depreciation) $33,129,624 $18,863,499 $26,594,551 $33,070,010 $50,407,793
One month of savings $2,753,563 $1,564,458 $2,207,845 $2,746,686 $4,191,773
Debt principal payment $0 $0 $0 $0 $0
Fixed asset additions $0 $0 $0 $0 $0
Total full costs (estimated) $35,883,187 $20,427,957 $28,802,396 $35,816,696 $54,599,566

Capital structure indicators

Liquidity info 2019 2020 2021 2022 2023
Months of cash 8.3 12.9 12.0 5.3 7.3
Months of cash and investments 21.1 37.0 31.3 25.6 21.8
Months of estimated liquid unrestricted net assets 1.7 11.5 13.5 8.4 6.9
Balance sheet composition info 2019 2020 2021 2022 2023
Cash $22,960,219 $20,216,462 $26,450,890 $14,626,496 $30,710,288
Investments $35,014,646 $37,604,040 $42,647,621 $55,776,973 $60,499,329
Receivables $16,343,005 $5,962,058 $6,674,241 $7,340,786 $6,264,235
Gross land, buildings, equipment (LBE) $2,173,967 $2,217,433 $2,222,670 $2,320,416 $2,392,981
Accumulated depreciation (as a % of LBE) 16.5% 20.3% 24.3% 28.1% 31.7%
Liabilities (as a % of assets) 47.9% 36.8% 34.6% 37.4% 48.9%
Unrestricted net assets $6,594,710 $19,808,146 $31,395,289 $24,721,366 $30,550,108
Temporarily restricted net assets $21,070,870 N/A N/A N/A N/A
Permanently restricted net assets $12,138,934 N/A N/A N/A N/A
Total restricted net assets $33,209,804 $21,967,524 $19,510,294 $25,196,735 $20,373,654
Total net assets $39,804,514 $41,775,670 $50,905,583 $49,918,101 $50,923,762

Key data checks

Key data checks info 2019 2020 2021 2022 2023
Material data errors No No No No No

Operations

The people, governance practices, and partners that make the organization tick.

Documents
Form 1023/1024 is not available for this organization

Chief Executive Officer

Shane Jacobson

Shane Jacobson is the Chief Executive Officer of the V Foundation. He is an accomplished foundation executive with experience leading record-setting campaigns that align philanthropic partnerships with ambitious goals. At the V Foundation, Jacobson and the staff have a laser-sharp focus on funding game-changing research and all-star scientists to accelerate victory over cancer and save lives. Prior to joining the organization, Jacobson served as the President & CEO of the University of Vermont Foundation. His team set an all-time high in fundraising through a highly successful $581 million campaign. Included in this total is nearly $300 million in support of academic medicine and patient care, as well as $43 million for athletics. They also generated substantial investments in research and scientific discovery by more than doubling the number of endowed faculty professorships and chairs, with more than 125 positions now at the University.

Number of employees

Source: IRS Form 990

The V Foundation

Officers, directors, trustees, and key employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of officer and director compensation data for this organization

The V Foundation

Highest paid employees

SOURCE: IRS Form 990

Compensation
Other
Related
Show data for fiscal year
Compensation data
Download up to 5 most recent years of highest paid employee data for this organization

The V Foundation

Board of directors
as of 07/27/2023
SOURCE: Self-reported by organization
Board of directors data
Download the most recent year of board of directors data for this organization
Board chair

Mr. Evan Goldberg

Jim Allegro

ESPN, Inc.

Robert C Bast, Jr., M.D.

M.D. Anderson Cancer Center

George Bodenheimer

ESPN, Inc.

Steven M Bornstein

NFL Network

Julie Maples

Fyrfly Venture Partners

George W Dennis III

Teague Campbell Dennis & Gorham, LLP

Michael W Krzyzewski

Duke University

Carl Liebert III

Keller Williams

Michael C MacDonald

Medifast

Geoffrey S Mason

Mainstay Communications

Joseph O Moore, M.D.

Duke Raleigh Cancer Center, Duke Raleigh Hospital

Lawrence F Probst III

Electronic Arts

Harry E. Rhoads, Jr.

Washington Speakers Bureau - Chief Executive Officer

Pamela Valvano Strasser

The V Foundation for Cancer Research

Nicholas P Valvano

The V Foundation for Cancer Research

Robert Valvano

ESPN, Inc.

Dick Vitale

ESPN, Inc. and ABC Sports

R.C. "Bucky" Waters

Duke University Medical Center - Retired Vice Chancellor for Special Projects; ESPN, Inc. & Madison Square Garden - Sports Commentator

Dereck Whittenburg

NC State University

David W. Williams

Whirlpool Corporation

David Fay

U.S. Golf Association

F.J. "Joe" Loughrey

Cummins, Inc.

Robert C. Nakasone

Toys "R" Us

Donna Orender

Orender Unlimited LLC

Constance E. Skidmore

PwC, LLP

Norby Williamson

ESPN, Inc.

Larry Woodard

Graham Stanley Advertising

Kevin Plank

Under Armour

Evan Goldberg

Oracle NetSuite Global Business Unit

Stuart Taylor

The Taylor Group

Mark King

Taco Bell

Jeff Berry

CAA Sports

Jay Bilas

Moore & Van Allen

Julie Chase

ChasePR

Nancy Davidson

Fred Hutchinson Cancer Research Center

Rita Ferro

Disney, Media & Entertainment

Matt Hong

Turner Sports

Michael B. Kastan, M.D., Ph.D.

Duke Cancer Institute

Clark Kinlin

Corning Optical Communications

William Nelson, M.D., Ph.D.

The Sidney Kimmel Comprehensive Cancer Center

James Pitaro

ESPN

Kevin Plank

Under Armour, Inc.

Buster Posey

San Francisco Giants

David Robinson

Admiral Capital Group

Sage Steele

ESPN

John W. Thiel

Merrill Lynch

Ciara Wilson

Grammy Award-Winning Singer/Songwriter

Russell Wilson

Denver Broncos

Rosa M. Gatti

ESPN, Inc.

Bob Lloyd

The V Foundation for Cancer Research

Contractors

Fiscal year ending
There are no fundraisers recorded for this organization.